Methodist Hospital is a hospital in the Lower Moyamensing neighborhood of South Philadelphia, affiliated with Thomas Jefferson University Hospital, Jefferson Hospital for Neuroscience and Thomas Jefferson University.

There are 204 beds in Jefferson Methodist Hospital.

During the past decade, Jefferson Methodist Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jefferson Methodist Hospital" #1 sponsor was "Thomas Jefferson University" with 4 trials, followed by "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored, "Sidney Kimmel Cancer Center at Thomas Jefferson University" with 1 trials sponsored and "University of California, San Francisco" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jefferson Methodist Hospital" #1 collaborator was "Duke University" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator, "Thomas Jefferson University" with 1 trials as a collaborator and "University of Washington" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Jefferson Methodist Hospital" are "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities" (1 trials), "Adult Acute Myeloid Leukemia With Del(5q)" (1 trials), "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)" (1 trials), "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)" (1 trials) and "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)" (1 trials). Many other conditions were trialed in "Jefferson Methodist Hospital" in a lesser frequency.

Most popular intervention types in "Jefferson Methodist Hospital" are "Drug" (4 trials), "Other" (4 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Questionnaire Administration" (3 trials), "Best Practice" (2 trials), "Quality-of-Life Assessment" (2 trials), "Azacitidine" (1 trials) and "Bariatric Full Liquid Diet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jefferson Methodist Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Jefferson Methodist Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Jefferson Methodist Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jefferson Methodist Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".